Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Altered distribution and function of splenic innate lymphoid cells in adult chronic immune thrombocytopenia.

Audia S, Moulinet T, Ciudad-Bonté M, Samson M, Facy O, Ortega-Deballon P, Saas P, Bonnotte B.

J Autoimmun. 2018 Jul 23. pii: S0896-8411(18)30250-6. doi: 10.1016/j.jaut.2018.07.015. [Epub ahead of print]

PMID:
30055825
2.

Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.

Samson M, Devilliers H, Ly KH, Maurier F, Bienvenu B, Terrier B, Charles P, Guillevin L, Besancenot JF, Liozon E, Fauchais AL, Loffroy R, Binquet C, Audia S, Seror R, Mariette X, Bonnotte B.

Eur J Intern Med. 2018 Jul 24. pii: S0953-6205(18)30240-1. doi: 10.1016/j.ejim.2018.06.008. [Epub ahead of print]

PMID:
30054122
3.

Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.

Terrier B, Pagnoux C, Perrodeau É, Karras A, Khouatra C, Aumaître O, Cohen P, Decaux O, Desmurs-Clavel H, Maurier F, Gobert P, Quémeneur T, Blanchard-Delaunay C, Bonnotte B, Carron PL, Daugas E, Ducret M, Godmer P, Hamidou M, Lidove O, Limal N, Puéchal X, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1150-1156. doi: 10.1136/annrheumdis-2017-212768. Epub 2018 May 3.

PMID:
29724729
4.

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

Charles P, Terrier B, Perrodeau É, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1143-1149. doi: 10.1136/annrheumdis-2017-212878. Epub 2018 Apr 25.

PMID:
29695500
5.

CT analysis of the aorta in giant-cell arteritis: a case-control study.

Berthod PE, Aho-Glélé S, Ornetti P, Chevallier O, Devilliers H, Ricolfi F, Bonnotte B, Loffroy R, Samson M.

Eur Radiol. 2018 Sep;28(9):3676-3684. doi: 10.1007/s00330-018-5311-8. Epub 2018 Mar 29.

PMID:
29600479
6.

[Immunosuppressive therapy and fertility preservation: Indications and methods].

Choux C, Cavalieri M, Barberet J, Samson M, Bonnotte B, Fauque P, Sagot P.

Rev Med Interne. 2018 Jul;39(7):557-565. doi: 10.1016/j.revmed.2018.02.010. Epub 2018 Feb 28. French.

PMID:
29500075
7.

Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients.

de Boysson H, Daumas A, Vautier M, Parienti JJ, Liozon E, Lambert M, Samson M, Ebbo M, Dumont A, Sultan A, Bonnotte B, Manrique A, Bienvenu B, Saadoun D, Aouba A.

Autoimmun Rev. 2018 Apr;17(4):391-398. doi: 10.1016/j.autrev.2017.11.029. Epub 2018 Feb 7. Review.

PMID:
29427822
8.

[Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?]

Samson M, Bonnotte B.

Rev Med Interne. 2018 Feb;39(2):75-77. doi: 10.1016/j.revmed.2017.11.003. Epub 2017 Dec 6. French. No abstract available.

PMID:
29217104
9.

Diagnosis of hyperferritinemia in routine clinical practice.

Lorcerie B, Audia S, Samson M, Millière A, Falvo N, Leguy-Seguin V, Berthier S, Bonnotte B.

Presse Med. 2017 Dec;46(12 Pt 2):e329-e338. doi: 10.1016/j.lpm.2017.09.028. Epub 2017 Nov 20. Review.

PMID:
29150231
10.

Biological treatments in giant cell arteritis & Takayasu arteritis.

Samson M, Espígol-Frigolé G, Terrades-García N, Prieto-González S, Corbera-Bellalta M, Alba-Rovira R, Hernández-Rodríguez J, Audia S, Bonnotte B, Cid MC.

Eur J Intern Med. 2018 Apr;50:12-19. doi: 10.1016/j.ejim.2017.11.003. Epub 2017 Nov 13. Review.

PMID:
29146018
11.

Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.

Estève C, Samson M, Guilhem A, Nicolas B, Leguy-Seguin V, Berthier S, Bonnotte B, Audia S.

PLoS One. 2017 Oct 30;12(10):e0187296. doi: 10.1371/journal.pone.0187296. eCollection 2017.

12.

[From pathogenesis of giant cell arteritis to new therapeutic targets].

Samson M, Bonnotte B.

Rev Med Interne. 2017 Oct;38(10):670-678. doi: 10.1016/j.revmed.2017.06.016. Epub 2017 Aug 8. Review. French.

PMID:
28800947
13.

Recent advances in our understanding of giant cell arteritis pathogenesis.

Samson M, Corbera-Bellalta M, Audia S, Planas-Rigol E, Martin L, Cid MC, Bonnotte B.

Autoimmun Rev. 2017 Aug;16(8):833-844. doi: 10.1016/j.autrev.2017.05.014. Epub 2017 May 28. Review.

PMID:
28564617
14.

Ustekinumab inhibits Th1 and Th17 polarisation in a patient with giant cell arteritis.

Samson M, Ghesquière T, Berthier S, Bonnotte B.

Ann Rheum Dis. 2018 Feb;77(2):e6. doi: 10.1136/annrheumdis-2017-211622. Epub 2017 May 13. No abstract available.

PMID:
28501800
15.

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.

Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE.

Autoimmun Rev. 2017 Jun;16(6):650-657. doi: 10.1016/j.autrev.2017.04.011. Epub 2017 Apr 18.

PMID:
28434948
16.

Pathogenesis of immune thrombocytopenia.

Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B.

Autoimmun Rev. 2017 Jun;16(6):620-632. doi: 10.1016/j.autrev.2017.04.012. Epub 2017 Apr 17. Review.

PMID:
28428120
17.

Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis.

Lopez A, Mariette X, Bachelez H, Belot A, Bonnotte B, Hachulla E, Lahfa M, Lortholary O, Loulergue P, Paul S, Roblin X, Sibilia J, Blum M, Danese S, Bonovas S, Peyrin-Biroulet L.

J Autoimmun. 2017 Jun;80:10-27. doi: 10.1016/j.jaut.2017.03.011. Epub 2017 Apr 2. Review.

PMID:
28381345
18.

Fcγ receptor expression on splenic macrophages in adult immune thrombocytopenia.

Audia S, Santegoets K, Laarhoven AG, Vidarsson G, Facy O, Ortega-Deballon P, Samson M, Janikashvili N, Saas P, Bonnotte B, Radstake TR.

Clin Exp Immunol. 2017 May;188(2):275-282. doi: 10.1111/cei.12935. Epub 2017 Feb 28.

19.

Giant Cell Arteritis-related Stroke: A Retrospective Multicenter Case-control Study.

de Boysson H, Liozon E, Larivière D, Samson M, Parienti JJ, Boutemy J, Maigné G, Martin Silva N, Ly K, Touzé E, Bonnotte B, Aouba A, Sacré K, Bienvenu B.

J Rheumatol. 2017 Mar;44(3):297-303. doi: 10.3899/jrheum.161033. Epub 2017 Jan 15.

PMID:
28089985
20.

B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia.

Audia S, Rossato M, Trad M, Samson M, Santegoets K, Gautheron A, Bekker C, Facy O, Cheynel N, Ortega-Deballon P, Boulin M, Berthier S, Leguy-Seguin V, Martin L, Ciudad M, Janikashvili N, Saas P, Radstake T, Bonnotte B.

J Autoimmun. 2017 Feb;77:89-95. doi: 10.1016/j.jaut.2016.11.002. Epub 2016 Nov 15.

PMID:
27863820
21.

Endovascular stent placement for chronic post-thrombotic symptomatic ilio-femoral venous obstructive lesions: a single-center study of safety, efficacy and quality-of-life improvement.

Falcoz MT, Falvo N, Aho-Glélé S, Demaistre E, Galland C, Favelier S, Pottecher P, Chevallier O, Bonnotte B, Audia S, Samson M, Terriat B, Midulla M, Loffroy R; Burgundy Research; Study Group on Treatment of Venous Diseases.

Quant Imaging Med Surg. 2016 Aug;6(4):342-352.

22.

A New Prognosis Score to Predict Mortality After Acute Pneumonia in Very Elderly Patients.

Putot A, Tetu J, Perrin S, Bailly H, Piroth L, Besancenot JF, Bonnotte B, Chavanet P, Charles PE, Sordet-Guépet H, Manckoundia P.

J Am Med Dir Assoc. 2016 Dec 1;17(12):1123-1128. doi: 10.1016/j.jamda.2016.07.018. Epub 2016 Sep 3.

PMID:
27600193
23.

Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement: A retrospective study in 112 patients.

Bouiller K, Audia S, Devilliers H, Collet E, Aubriot MH, Leguy-Seguin V, Berthier S, Bonniaud P, Chavanet P, Besancenot JF, Vabres P, Martin L, Samson M, Bonnotte B.

Medicine (Baltimore). 2016 Jul;95(28):e4238. doi: 10.1097/MD.0000000000004238.

24.

Involvement and prognosis value of CD8(+) T cells in giant cell arteritis.

Samson M, Ly KH, Tournier B, Janikashvili N, Trad M, Ciudad M, Gautheron A, Devilliers H, Quipourt V, Maurier F, Meaux-Ruault N, Magy-Bertrand N, Manckoundia P, Ornetti P, Maillefert JF, Besancenot JF, Ferrand C, Mesturoux L, Labrousse F, Fauchais AL, Saas P, Martin L, Audia S, Bonnotte B.

J Autoimmun. 2016 Aug;72:73-83. doi: 10.1016/j.jaut.2016.05.008. Epub 2016 May 25.

PMID:
27236507
25.

Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome.

Grimaldi-Bensouda L, Nordon C, Michel M, Viallard JF, Adoue D, Magy-Bertrand N, Durand JM, Quittet P, Fain O, Bonnotte B, Morin AS, Morel N, Costedoat-Chalumeau N, Pan-Petesch B, Khellaf M, Perlat A, Sacre K, Lefrere F, Abenhaim L, Godeau B; Group for the PGRx-ITP Study.

Haematologica. 2016 Sep;101(9):1039-45. doi: 10.3324/haematol.2016.146373. Epub 2016 May 26.

26.

Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life.

Pugnet G, Pagnoux C, Terrier B, Perrodeau E, Puéchal X, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quemeneur T, Blanchard-Delaunay C, Godmer P, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group.

Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S54-9. Epub 2016 Mar 25.

PMID:
27049404
27.

[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion].

Mathian A, Arnaud L, Adoue D, Agard C, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Sibilia J, Viallard JF, Viau Brabant A, Hanslik T, Amoura Z; le groupe France lupus érythémateux systémique réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.

Rev Med Interne. 2016 May;37(5):307-20. doi: 10.1016/j.revmed.2016.01.005. Epub 2016 Feb 16. French.

PMID:
26899776
28.

Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).

Bienvenu B, Ly KH, Lambert M, Agard C, André M, Benhamou Y, Bonnotte B, de Boysson H, Espitia O, Fau G, Fauchais AL, Galateau-Sallé F, Haroche J, Héron E, Lapébie FX, Liozon E, Luong Nguyen LB, Magnant J, Manrique A, Matt M, de Menthon M, Mouthon L, Puéchal X, Pugnet G, Quemeneur T, Régent A, Saadoun D, Samson M, Sène D, Smets P, Yelnik C, Sailler L, Mahr A; Groupe d’Étude Français des Artérites des gros Vaisseaux, under the Aegis of the Filière des Maladies Auto-Immunes et Auto-Inflammatoires Rares.

Rev Med Interne. 2016 Mar;37(3):154-65. doi: 10.1016/j.revmed.2015.12.015. Epub 2016 Jan 29.

PMID:
26833145
29.

Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients.

Putot A, Tetu J, Perrin S, Bailly H, Piroth L, Besancenot JF, Bonnotte B, Chavanet P, d'Athis P, Charles PE, Sordet-Guépet H, Manckoundia P.

Eur J Clin Microbiol Infect Dis. 2016 Mar;35(3):489-95. doi: 10.1007/s10096-015-2565-9. Epub 2016 Jan 11.

PMID:
26753994
30.

[Pathogenesis of large vessel vasculitis].

Samson M, Bonnotte B.

Rev Med Interne. 2016 Apr;37(4):264-73. doi: 10.1016/j.revmed.2015.10.350. Epub 2015 Nov 24. Review. French.

PMID:
26620872
31.

T Lymphocyte Plasticity in Autoimmunity and Cancer.

Janikashvili N, Chikovani T, Audia S, Bonnotte B, Larmonier N.

Biomed Res Int. 2015;2015:540750. doi: 10.1155/2015/540750. Epub 2015 Oct 25. No abstract available.

32.

T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1.

Trad M, Gautheron A, Fraszczak J, Alizadeh D, Larmonier C, LaCasse CJ, Centuori S, Audia S, Samson M, Ciudad M, Bonnefoy F, Lemaire-Ewing S, Katsanis E, Perruche S, Saas P, Bonnotte B.

Biomed Res Int. 2015;2015:891236. doi: 10.1155/2015/891236. Epub 2015 Sep 30.

33.

Is there still a place for "old therapies" in the management of immune thrombocytopenia?

Audia S, Godeau B, Bonnotte B.

Rev Med Interne. 2016 Jan;37(1):43-9. doi: 10.1016/j.revmed.2015.08.007. Epub 2015 Oct 1.

34.

Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab.

Mahévas M, Michel M, Vingert B, Moroch J, Boutboul D, Audia S, Cagnard N, Ripa J, Menard C, Tarte K, Mégret J, Le Gallou S, Patin P, Thai L, Galicier L, Bonnotte B, Godeau B, Noizat-Pirenne F, Weill JC, Reynaud CA.

J Autoimmun. 2015 Aug;62:22-30. doi: 10.1016/j.jaut.2015.05.006. Epub 2015 Jun 23.

PMID:
26112660
35.

[Inflammation].

Audial S, Bonnotte B.

Rev Prat. 2015 Mar;65(3):403-8. Review. French. No abstract available.

PMID:
26016209
36.

[Inflammatory syndrome: an important marker for the clinician].

Audia S, Bonnotte B.

Rev Prat. 2015 Mar;65(3):398. French. No abstract available.

PMID:
26016205
37.

Good syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications.

Malphettes M, Gérard L, Galicier L, Boutboul D, Asli B, Szalat R, Perlat A, Masseau A, Schleinitz N, Le Guenno G, Viallard JF, Bonnotte B, Thiercelin-Legrand MF, Sanhes L, Borie R, Georgin-Lavialle S, Fieschi C, Oksenhendler E; DEFicit Immunitaire de l'adulte Study Group.

Clin Infect Dis. 2015 Jul 15;61(2):e13-9. doi: 10.1093/cid/civ269. Epub 2015 Mar 31.

PMID:
25828999
38.

[Diagnosis of an increased serum level of ferritin].

Lorcerie B, Audia S, Samson M, Millière A, Falvo N, Leguy-Seguin V, Berthier S, Bonnotte B.

Rev Med Interne. 2015 Aug;36(8):522-9. doi: 10.1016/j.revmed.2014.12.007. Epub 2015 Jan 29. French.

39.

Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.

Janikashvili N, Trad M, Gautheron A, Samson M, Lamarthée B, Bonnefoy F, Lemaire-Ewing S, Ciudad M, Rekhviashvili K, Seaphanh F, Gaugler B, Perruche S, Bateman A, Martin L, Audia S, Saas P, Larmonier N, Bonnotte B.

J Allergy Clin Immunol. 2015 Jun;135(6):1614-24.e4. doi: 10.1016/j.jaci.2014.12.1868. Epub 2015 Jan 25.

PMID:
25630940
40.

[Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion].

Arnaud L, Mathian A, Adoue D, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Papo T, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Schmidt J, Sibilia J, Viallard JF, Viau Brabant A, Wahl D, Bruckert E, Amoura Z; groupe France Lupus Érythémateux systémique Réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.

Rev Med Interne. 2015 Jun;36(6):372-80. doi: 10.1016/j.revmed.2014.10.009. Epub 2014 Nov 14. French.

PMID:
25455954
41.

Measurement of interatrial dyssynchrony using tissue Doppler imaging predicts functional capacity and cardiac involvement in systemic sclerosis.

Eicher JC, Berthier S, Aho LS, Lorcerie B, Bonnotte B, Laurent G.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-171-6. Epub 2014 Nov 5.

PMID:
25372800
42.

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.

Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quémeneur T, Blanchard-Delaunay C, Godmer P, Puéchal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L; French Vasculitis Study Group.

N Engl J Med. 2014 Nov 6;371(19):1771-80. doi: 10.1056/NEJMoa1404231.

43.

Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE.

Devilliers H, Amoura Z, Besancenot JF, Bonnotte B, Pasquali JL, Wahl D, Maurier F, Kaminsky P, Pennaforte JL, Magy-Bertrand N, Arnaud L, Binquet C, Guillemin F, Bonithon-Kopp C.

Rheumatology (Oxford). 2015 May;54(5):940-9. doi: 10.1093/rheumatology/keu410. Epub 2014 Oct 30.

PMID:
25361539
44.

Should mild hypogammaglobulinemia be managed as severe hypogammaglobulinemia? A study of 389 patients with secondary hypogammaglobulinemia.

Blot M, Boyer P, Samson M, Audia S, Devilliers H, Leguy V, Berthier S, Besancenot JF, Lorcerie B, Lakomy D, Bonnotte B.

Eur J Intern Med. 2014 Nov;25(9):837-42. doi: 10.1016/j.ejim.2014.09.009. Epub 2014 Oct 11.

PMID:
25307285
45.

Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia.

Audia S, Rossato M, Santegoets K, Spijkers S, Wichers C, Bekker C, Bloem A, Boon L, Flinsenberg T, Compeer E, van den Broek T, Facy O, Ortega-Deballon P, Berthier S, Leguy-Seguin V, Martin L, Ciudad M, Samson M, Trad M, Lorcerie B, Janikashvili N, Saas P, Bonnotte B, Radstake TR.

Blood. 2014 Oct 30;124(18):2858-66. doi: 10.1182/blood-2014-03-563445. Epub 2014 Sep 16.

46.

Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis.

Bouiller K, Samson M, Eicher JC, Audia S, Berthier S, Leguy V, Humbert O, Martin L, Lorgis L, Cottin Y, Bonnotte B, Lorcerie B.

Intern Med J. 2014 Sep;44(9):928-31. doi: 10.1111/imj.12525.

PMID:
25201426
47.

Does tocilizumab indeed reduce the frequency of Th17 cells? Comment on the article by Thiolat et al.

Samson M, Audia S, Ornetti P, Maillefert JF, Janikashvili N, Bonnotte B.

Arthritis Rheumatol. 2014 Sep;66(9):2639-40. doi: 10.1002/art.38718. No abstract available.

48.

Stroke associated with giant cell arteritis: a population-based study.

Samson M, Jacquin A, Audia S, Daubail B, Devilliers H, Petrella T, Martin L, Durier J, Besancenot JF, Lorcerie B, Giroud M, Bonnotte B, Béjot Y.

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):216-21. doi: 10.1136/jnnp-2014-307614. Epub 2014 Apr 29.

PMID:
24780954
49.

PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15.

Hanke NT, LaCasse CJ, Larmonier CB, Alizadeh D, Trad M, Janikashvili N, Bonnotte B, Katsanis E, Larmonier N.

Eur J Immunol. 2014 Aug;44(8):2489-2499. doi: 10.1002/eji.201343803. Epub 2014 May 23.

50.

[Immunologic mechanisms involved in rituximab failure during adult immune thrombocytopenia].

Audia S, Saas P, Bonnotte B.

Med Sci (Paris). 2014 Mar;30(3):239-42. doi: 10.1051/medsci/20143003006. Epub 2014 Mar 31. French. No abstract available.

Supplemental Content

Loading ...
Support Center